HBI
55
-4
ISRG
76
2
DE
56
10
GPC
37
2
ETN
79
4
ALLE
44
7
TEL
66
6
HPE
61
6
AMGN
38
-6
PDCO
38
3
KO
44
2
EQR
59
5
EOG
56
-2
TXT
52
4
RHI
57
3
PRU
62
5
EMN
56
7
VNO
50
-9
SRE
66
3
ROK
47
-8
HBI
55
-4
ISRG
76
2
DE
56
10
GPC
37
2
ETN
79
4
ALLE
44
7
TEL
66
6
HPE
61
6
AMGN
38
-6
PDCO
38
3
KO
44
2
EQR
59
5
EOG
56
-2
TXT
52
4
RHI
57
3
PRU
62
5
EMN
56
7
VNO
50
-9
SRE
66
3
ROK
47
-8
Financhill
Back

Catalyst Pharmaceuticals 10K Form

Sell
46

CPRX
Catalyst Pharmaceuticals

Last Price:
21.34
Seasonality Move:
4.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPRX News And Ratings

See the #1 stock for the next 7 days that we like better than CPRX

CPRX Financial Statistics

Sales & Book Value

Annual Sales: $398.2M
Cash Flow: $72.61M
Price / Cash Flow: 11.6
Annual Sales: $5.54
Price / Book: 3.81

Profitability

EPS (TTM): 1.18000
Net Income (TTM): $142.8M
Gross Margin: $346.24M
Return on Equity: 27.81%
Return on Assets: 23.73%

Catalyst Pharmaceuticals Earnings Forecast

Key Catalyst Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 22 years for CPRX is 86.95%.
  • The Selling, General & Administrative Expenses for CPRX have been equal to 33.58% of Gross Profit Margin.
  • The Research & Development expenses have been 23.39% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 22 years have been positive in 10 years.

Catalyst Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CPRX
CUSIP: 14888U
Website: catalystpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.11
Quick Ratio: 4.75

Price-to-Earnings

Trailing P/E Ratio: 33.52
Forward P/E Ratio: 10.09

CPRX Technical Analysis vs Fundamental Analysis

Sell
46
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy or a Sell?